A 50-year-old male with a positive family history of prostate cancer has come to you for a screening test. The most sensitive screening test to pickup prostate cancer is:
**Core Concept**
Prostate cancer screening aims to detect early signs of the disease, particularly in high-risk populations with a positive family history. The most sensitive screening tests rely on detecting biomarkers or changes in prostate tissue that are indicative of cancer.
**Why the Correct Answer is Right**
The most sensitive screening test for prostate cancer is the Prostate-Specific Antigen (PSA) test. Elevated levels of PSA in the blood can indicate the presence of prostate cancer, even in the absence of symptoms. This is because PSA is a protein produced by the prostate gland, and cancerous cells can lead to an overproduction of PSA. The PSA test has a higher sensitivity compared to other screening methods, such as digital rectal examination (DRE) or transrectal ultrasound (TRUS).
**Why Each Wrong Option is Incorrect**
**Option A:** Digital Rectal Examination (DRE) is less sensitive than PSA testing for detecting prostate cancer, as it relies on the examiner's ability to palpate the prostate gland and detect abnormalities. While DRE can provide valuable information, it is not as sensitive as PSA testing.
**Option B:** Transrectal Ultrasound (TRUS) is a diagnostic tool that can be used to guide prostate biopsies or monitor treatment response. However, it is not a primary screening test for prostate cancer and is typically used in conjunction with PSA testing.
**Option C:** Prostate-Specific Antigen Density (PSAD) is a refinement of PSA testing that takes into account the patient's prostate volume. While PSAD can provide more accurate results, it is not the most sensitive screening test for prostate cancer.
**Clinical Pearl / High-Yield Fact**
The American Urological Association (AUA) recommends PSA testing for men aged 55-69 years, with a family history of prostate cancer or other risk factors. However, the decision to screen should be individualized and based on the patient's overall health and risk profile.
**Correct Answer:** C.